Also under the umbrella of noteworthy achievements in validating neuronal nsEV constituents as CNS disorder biomarkers, levels of alpha-synuclein (α-Syn) carried by bloodborne neuronal nsEVs have been observed to correlate with PD severity [5]. This evidence concerns the gene SNCA and central nervous system disorder.